Ignite Creation Date:
2024-05-06 @ 1:14 AM
Last Modification Date:
2024-10-26 @ 11:01 AM
Study NCT ID:
NCT01764477
Status:
COMPLETED
Last Update Posted:
2017-08-17
First Post:
2012-12-12
Brief Title:
Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma
Sponsor:
Prism Pharma Co Ltd
Organization:
Prism Pharma Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-04
Start Date Type:
None
Primary Completion Date:
2015-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-10
Completion Date Type:
ACTUAL
First Submit Date:
2012-12-12
First Submit QC Date:
January 7 2013
Study First Post Date:
2013-01-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-16
Last Update Post Date:
2017-08-17
Last Update Post Date Type:
ACTUAL